Abstract
Sacituzumab govitecan (sacituzumab govitecan-hziy; TrodelvyT) is a Trop-2-directed antibody conjugated to a topoisomerase I inhibitor (SN-38) that is ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
